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Summary 
Current-day radiotherapy systems do not account for tumor rotation, and dosimetric errors may 
result. This study reports a system that integrates a prototype electromagnetic tracking system to 
detect tumor translation and rotation with a dynamic multileaf collimator system that in real-time 
adapts the radiation beam to the translation and rotating tumor. Results show a rotation accuracy 
correction error of less than 1 degree. Dosimetric studies showed a three-fold improvement in 
target dose accuracy compared to current-day clinically available technology. 
  
Introduction 
Tumor motion can significantly influence the accuracy of radiation therapy. Therefore, margins 
are included in the planning target volume to account for the range of target motion. This 
expansion ensures tumor coverage, but also leads to higher dose to normal tissue. To reduce 
these margins, dynamic multileaf collimator (DMLC) tracking has been investigated because it 
can achieve high-dose conformality with minimal sacrifice of treatment efficiency. 
 
In the past few years, researchers have empirically investigated DMLC tracking on a variety of 
commercial platforms including AccuKnife (1), Siemens (2), Tomotherapy (3, 4,) and Varian (5, 
6, 7, 8). This work to date has focused on adapting to translational motion of the targets. 
Rotational target motion has not previously been studied. However, lung tumors and prostate 
tumors have been observed to rotate as much as 45° and 25°, respectively (9, 10). Significant 
rotations have also been reported for liver tumors and a gastrointestinal stromal tumor during 
respiration (11, 12). Table 1 summarizes tumor rotational movement studies for a variety of 
tumor sites. 
As with translational motion, rotational motion can severely compromise target dose coverage 
and normal tissue sparing if it is not accounted for. Rotation may cause part of the target volume 
to move out of the treatment field and result in underdose (13, 14). Recently, Li et al. (15) found 
that the dosimetric discrepancies caused by prostate rotation were more significant than those 
caused by translational intrafractional motion. They concluded that treatment margins may be 
reduced significantly if the prostate rotation can be controlled to within 1° in all directions. 
 
Strategies of rotational motion correction for intensity-modulated radiation therapy (IMRT) 
treatment have been studied (14, 16, 17, 18) and gantry, collimator, and/or couch angle 
adjustment has been proposed. However, existing studies are limited to interfraction rotational 
motion and require manual intervention for each beam during radiation therapy delivery and are 
not real-time. The aim of the current study was to investigate and evaluate the geometric and 
dosimetric performance of an electromagnetically guided real-time DMLC tracking system to 
detect and adapt to intrafractional tumor rotation. 
 
Methods and Materials 
Electromagnetically guided real-time DMLC tracking system 
A research four-dimensional localization system (Calypso Medical Technologies Inc., Seattle, 
WA) was integrated with a real-time DMLC tracking system employed on a Varian IX linear 
accelerator (Varian Medical System, Palo Alto, CA) with a 120-leaf MLC, which has previously 
been used for studying DMLC tracking in the presence of translational motion (19, 20, 21). In 
this work, the four-dimensional localization system electromagnetically measured the positions 
of the transponders and provided the target translation and rotation information. The data stream 
was input to the DMLC tracking software, where the beam aperture generated by the treatment 
planning system (and indexed by monitor units for IMRT) was translated and rotated based on 
the data stream values to generate an ideal aperture. This ideal aperture was typically 
undeliverable, because of physical constraints such as finite MLC leaf widths, and more 
importantly the paired leaf structure. An optimization framework was used to find, among all 
deliverable MLC configurations, the one that is closest to the ideal aperture, where closeness is 
defined rigorously as the cumulative cost in terms of underdose (to target) and overdose (to 
healthy tissue) (22). The translation and rotation adapted MLC configuration was sent to the 
DMLC controller. The time delay of the system was measured to be 193 ms (19). No prediction 
algorithm was used to account for the time delay as the algorithms in the prototype system 
currently only predict translational motion. 
 
Geometric study 
The experimental setup is shown in Fig. 1 and Fig. 2. To test the geometric accuracy, three 3-
mm-diameter tungsten balls (hereafter referred to as "markers") were embedded in a puck, along 
with implanted electromagnetic transponders. Ciné electronic portal imaging device (EPID) 
images at 10.5 Hz were acquired for a D-shape aperture beam, from which the beam aperture and 
the positions of radio-opaque markers were simultaneously observed. The EPID is an appropriate 
measuring tool for this study as it can independently observe the target and beam rotation. A 
Matlab (Mathworks, Natick, MA) program was written to process EPID images and analyze the 
match between target rotation and MLC beam aperture rotation. This application automatically 
extracted the marker positions from EPID images and calculated the target rotation angle. The 
observed marker configuration provided the “ground-truth” for an instantaneous target rotation 
angle, whereas the extracted orientation of the beam aperture represented the tracking results. 
Both the target positions and beam aperture were detected using threshold-based segmentation 
methods. The beam aperture rotation angle was estimated from the slope of straight sideline on 
the D-shape beam (Fig. 3). The discrepancy between these two angular quantities, the beam-
target rotational alignment difference, was used as the performance metric for geometric 
accuracy. 
Both fixed rotation and active rotation were studied. Here, fixed rotated target signifies the target 
is rotated prior to treatment and does not move during treatment, and actively rotating target 
signifies that the target is rotating during treatment. The rotation angle values were chosen to 
span the largest (to date) observed rotation, 46° (Table 1). For fixed rotation, the phantom was 
rotated to a group of preset angles (5–55° in 5° increments) by rotating the couch. At least 10 
EPID images were acquired at each couch angle. EPID images of DMLC aperture tracking for 
the target rotated to 0°, 10°, 20°, 30°, 40°, and 50° are shown in Fig. 4. For dynamic rotation, the 
couch was rotated continuously from 0° to 60° and from 60° to 0° via control at the treatment 
console at a speed of approximately 4°/sec. Approximately 40 EPID images were acquired 
during the dynamic rotation. The gantry angle and collimator angles were kept at 180° (Varian 
Scale) so that the beam central axis was perpendicular to the rotational plane. 
Dosimetric study 
The experimental setup for the dosimetric study was the same as the geometric study. A PTW 
two-dimensional ion chamber array (PTW, Freiburg, Germany) with 2 cm of solid water buildup 
was placed between the couch and puck with embedded transponders for dosimetric 
measurement. A magnetic shielding “Faraday cage” (two layers of aluminum foil) was placed 
around the PTW detectors and cable to reduce the current induced by the electromagnetic array 
in the ion chamber array. This shielding reduced the leakage dose from 0.3 Gy to 0.003 Gy over 
1 min. As in the geometric experiment, the couch was rotated to simulate fixed and active 
rotational movement of the tumor. 
 
In the dosimetric study, we used a conformal ellipse beam (minor and major axes 5 cm and 7 cm, 
respectively) and two lung dynamic (sliding window) IMRT beams, because lung tumors have 
been observed to undergo large rotational motion. For each beam, we tested the following five 
delivery modes: 1) nonrotated target (reference), during which the target was kept still in the 
planned position without any rotation—the dosimetric results represent the ideal situation; 2) 
fixed rotated target with tracking, during which the target was rotated to fixed angles (15°, 30°, 
45°, 60°) with active real-time DMLC tracking; 3) fixed rotated target with tracking, during 
which the target was rotated to fixed angles with no motion adaptation during delivery; 4) active 
rotating target with tracking; and 5) active rotating target without tracking, during which the 
target was continuously rotated back and forth at a speed of ∼4°/sec between 0° and 60°. The 
discrepancy between 1) and 3) and 1) and 5) reflects the dosimetric impact of uncompensated 
target rotation. Two hundred monitor units were delivered for all beams. Dosimetric performance 
of the latter four modes was measured and compared with the reference distribution using a 3-
mm/3% γ-test with a 5% low-dose threshold, below which differences were ignored. The 
comparison method is shown in Fig. 5. 
Results 
The geometric results for fixed rotation and active rotation are shown in Table 2 and Table 3, 
respectively. Overall, the geometric experimental results indicated that the beam-target rotational 
alignment difference was 0.3°± 0.6° for fixed rotation and 0.3° ± 1.3° for active rotation. Both 
results demonstrated sub-2° accuracy for the tracking system with most of the results within ±1°. 
Because of system latency and the EPID integration time, the beam-target alignment difference 
for active rotation was larger than the fixed rotation beam-target alignment difference, as 
expected, and exhibited directional dependence. Given the 4°/sec rotation and 193-ms system 
latency, a directionally dependent 0.8° systematic error is estimated for active rotation. This error 
could be reduced with lower system latency and/or developing a prediction algorithm to estimate 
rotation. 
The dose distribution from fixed rotated target tracking and actively rotating target tracking were 
similar to that of the reference obtained with a nonrotated target. Example isodose curves of 
comparing rotation tracking and no rotation tracking to IMRT fields are shown in Fig. 6. The 
plans delivered without rotation tracking tended to have misshaped and shifted dose distributions 
compared with the rotation tracking IMRT distributions because of a combination of geometric 
error and the interplay effect (23). Both the geometric error and interplay effect depend on the 
starting rotation angle. 
The 3-mm/3% γ-test results are shown in Fig. 7. The rotation tracking results demonstrated a 
significantly better match for all cases. The average failure rate for the γ-test for a fixed rotated 
target was 11% with tracking and 36% without tracking; the average failure rate for an actively 
rotating target was 9% with tracking and 35% without tracking. 
There was some treatment efficiency loss with DMLC tracking because of beam holds. Beam 
holds occur when any one of the MLC leaves cannot reach the desired position to within the 
preset tolerance (0.5 cm for these cases). Table 4 summarizes the treatment efficiency with the 
change of rotation angle. A larger rotation angle required more MLC position adjustment for the 
treatment and caused a beam hold because of limited maximum leaf velocities (∼3.60 cm/sec) 
(24, 25), resulting in a longer treatment time for the same monitor unit delivery. Therefore, 
treatment efficiency decreased as the rotation angle increased. The lowest treatment efficiency 
with DMLC tracking was 66% when the target was rotated 60°, which is still reasonable for 
clinical implementation. 
Discussion 
Electromagnetically guided DMLC adaptation to rotational target motion has been investigated. 
The geometric accuracy and dose distributions to fixed and actively rotating targets with DMLC 
tracking were significantly superior to those without tracking. In most cases, the rotational error 
was within 1°, which—according to an independent prostate study by Li et al.(15)—would allow 
treatment margins to be reduced significantly. It should also be noted that the geometric and 
dosimetric results mentioned here represent an upper bound of error. Reductions in measurement 
error, system latency, and faster and/or thinner MLC leaves, DMLC tracking algorithm 
improvements, and including rotational prediction would further reduce the geometric and dose 
differences observed from the ideal nonrotated case. 
 
As expected, when the rotation angle increased from 15° to 60°, the failure rate for the without 
tracking measurement increased dramatically from 15% to 52%. Larger rotation movement led 
to larger discrepancy. In contrast, the failure rate for target tracking measurement increased 
slightly from an average of 8–14% and was more immune to the adverse impact of rotational 
motion. 
 
The study was limited to rotational movements in the sagittal plane, perpendicular to the beam 
direction or “in-plane” rotation. A further limitation was that the dynamic rotation used a 
constant angular velocity of 4°/sec. Future rotation detection and adaptation study is planned for 
more complex and realistic patient rotation data and more complex delivery, including intensity-
modulated ARC therapy delivery. Dedicated phantoms will need to be developed for this 
purpose. 
 
Currently, the prototype implemented rotation detection and adaptation by using the 
electromagnetic input data. Electromagnetic-guided tracking is very attractive because it does not 
give extra radiation dose to patients. However, in principle, other guidance methods that can give 
rotational motion, including those used for the studies in Table 1, such as kV imaging, MV 
imaging, ultrasound, and MRI could be integrated with DMLC adaptation, even offering the 
potential to adapt to target deformation in real time. 
 
An obvious alternate approach to using the DMLC to account for real-time target rotation is to 
use the existing linear accelerator collimator. Some manufacturers are offering the ability to vary 
the collimator angle during treatment delivery (though not in a real-time feedback sense). 
Limitations of using the collimator to account for rotation are the inability to simultaneously 
account for translation, the collimator rotation velocity limitation (typically 6 or 12°/sec 
maximum) and the inability to account for out-of-plane rotation (though not included in the 
current study, out-of-plane rotation can in principle be corrected for via DMLC adaptation). 
Combining DMLC adaptation with collimator rotation would be an interesting avenue for future 
research. 
 
One undesirable aspect of DMLC tracking is the increased dose outside the desired field aperture 
due to the “adjacent closed leaf pairs” (6). These adjacent closed leaf pairs can be seen above and 
below the open aperture in Fig. 3, Fig. 4. These leaves are not participating in defining the 
current treatment field, but will define the treatment field if there is a target motion perpendicular 
to the leaf aperture. The number of adjacent closed leaf pairs is estimated from the extent of 
target motion in the perpendicular direction. Two adjacent closed leaf pairs were used for these 
measurements (the number is a variable within the DMLC tracking software). The impact of 
these leaves could be reduced with double focused leaves (lower leakage) and faster leaf 
velocities (fewer adjacent closed leaf pairs needed). 
 
Conclusion 
For the first time, real-time target rotation has been accurately detected and adapted to during 
radiation therapy treatment via DMLC adaptation. The beam-target rotational alignment 
difference was sub-2°. Dose distributions to rotated and rotating targets with DMLC tracking 
were significantly superior to those without tracking. 
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Table 2. Summary of geometric accuracy for fixed rotated target measurements 
Target rotation 
angle (°) 
Beam aperture 
rotation (°) 
Beam-target rotational alignment 
difference (°) 
5.6 5.1 −0.5 
10.1 10.2 0.0 
15.6 15.0 −0.6 
20.5 20.1 −0.3 
25.1 25.2 0.1 
30.6 30.2 −0.4 
40.7 39.9 −0.8 
44.8 45.3 0.5 
50.1 50.3 0.1 
55.7 55.1 −0.6 
Combined −0.3 ± 0.6 (1 SD) 
 
 
 
  
Table 3. Summary of geometric accuracy for actively rotating target experiments 
Summary Target rotation from 0° 
to 60° 
Target rotation from 60° to 0° 
Exp 1 Exp 2 Exp 3 Exp 
1 
Exp 
2 
Exp 3 
Average beam-target rotational 
difference (°) 
1.2 1.7 0.6 −0.4 −1.7 0.2 
SD (°) 0.6 0.8 0.5 0.6 0.6 0.6 
Combined over 3 experiments (°) 1.2 ± 0.8 −0.6 ± 1.0 
Combined over 6 experiments (°) 0.3 ± 1.3 
 
 
 
Table 4. Summary of treatment delivery efficiency with different target rotation angles 
Treatment efficiency 15° 
rotation 
30° 
rotation 
45° 
rotation 
60° 
rotation 
Active 
rotation 
Conformal beam 100% 100% 100% 90.4% 85.7% 
Intensity-modulated 
radiotherapy beam 1 
90.0% 80.5% 76.7% 65.7% 81.2% 
Intensity-modulated 
radiotherapy beam 2 
98.0% 93.5% 88.9% 81.6% 87.7% 
The delivery efficiency is defined as the percentage of the time to deliver the reference beam divided by the 
time taken to deliver the beam accounting for rotation. 
 
 
  
  
Fig. 1. Experimental setup: the target rotation was performed by rotating the couch with electromagnetic 
transponders and an electromagnetically shielded PTW two-dimensional ion chamber array. The beam rotation 
was controlled by a real-time dynamic multileaf collimator tracking system taking the transponder rotation 
measurements as input. 
 
  
  
Fig. 2. Flowchart of electromagnetically guided real-time dynamic multileaf collimator rotation tracking. 
 
  
  
Fig. 3. The geometric accuracy was measured using the electronic portal imaging device. The target rotation 
angle was determined by the orientation of the embedded markers. The beam aperture rotation angle was 
estimated from the slope of the straight edge on the D-shape. The beam-target rotational alignment difference is 
the difference between the beam aperture rotation angle and the target rotation angle. 
 
  
  
Fig. 4. Example electronic portal imaging device images, showing the radiopaque markers representing the 
target rotation and the beam rotation shown with the multileaf collimator aperture (red outlines). Target rotation 
can be clearly observed through the green triangle rotation, which is formed by three markers (red, blue, and 
yellow). 
 
  
 Fig. 5. Example of dosimetric comparison: dosimetric measurement of an intensity-modulated radiotherapy 
(IMRT) beam with an actively rotating target with tracking (upper left) and rotating target without tracking 
(upper right) were compared with the reference dosimetric measurement of the same IMRT beam with a 
nonrotated target (upper middle) using a the 3%/3 mm γ-test. The isodose comparison results are shown in the 
bottom row. 
 
  
  
Fig. 6. Example of high-dose region isodose curves for an intensity-modulated radiotherapy field. The red 
squares indicate points failing the 3%/3 mm γ-test. Left: actively rotating target with tracking (solid lines); 
nonrotated target (dashed lines). Right: actively rotating target without tracking (solid lines); nonrotated target 
(dashed lines). 
 
 
  
  
Fig. 7. Dosimetric result summary: the percentage of dose values that failed the 3%/3 mm γ-test with and 
without tracking for conformal and intensity-modulated radiotherapy beams. 
